273 related articles for article (PubMed ID: 30310047)
1. Safety and Efficacy of Once-Daily Prolonged-Release Tacrolimus in Living Donor Liver Transplantation: An Open-Label, Prospective, Single-Arm, Phase 4 Study.
Lee EC; Kim SH; Park SJ
Ann Transplant; 2018 Oct; 23():713-720. PubMed ID: 30310047
[TBL] [Abstract][Full Text] [Related]
2. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.
Kim SH; Lee SD; Kim YK; Park SJ
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):374-9. PubMed ID: 26256081
[TBL] [Abstract][Full Text] [Related]
3. Beta Cell Function and Insulin Resistance After Conversion from Tacrolimus Twice-Daily to Extended-Release Tacrolimus Once-Daily in Stable Renal Transplant Recipients.
Ruangkanchanasetr P; Sanohdontree N; Supaporn T; Sathavarodom N; Satirapoj B
Ann Transplant; 2016 Dec; 21():765-774. PubMed ID: 27980321
[TBL] [Abstract][Full Text] [Related]
4. Early Conversion From Twice-Daily Tacrolimus to Prolonged-Release Tacrolimus in Liver Transplantation: A Single-Center Experience.
Ogura Y; Imai H; Kamei H; Hori T; Kurata N; Onishi Y
Ann Transplant; 2016 Jul; 21():448-55. PubMed ID: 27432248
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of once-daily modified-release tacrolimus in liver transplant recipients: a multicenter postmarketing surveillance in Japan.
Uemoto S; Abe R; Horike H; So M
Transplant Proc; 2014 Apr; 46(3):749-53. PubMed ID: 24767340
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Conversion to Once-Daily Tacrolimus from Twice-Daily Tacrolimus in Pediatric Liver Transplant Recipients.
An S; Lee S; Rhu J; Kim JM; Choi GS; Joh JW
J Pediatr Surg; 2023 Oct; 58(10):2054-2058. PubMed ID: 37277238
[TBL] [Abstract][Full Text] [Related]
7. Safe One-to-One Dosage Conversion From Twice-Daily to Once-Daily Tacrolimus in Long-Term Stable Recipients After Liver Transplantation.
Wu YJ; Lin YH; Yong CC; Li WF; Wang SH; Wang CC; Lin TL; Chen CL; Lin CC
Ann Transplant; 2016 Jan; 21():30-4. PubMed ID: 26782179
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of once-daily modified-release tacrolimus in kidney transplant recipients: interim analysis of multicenter postmarketing surveillance in Japan.
Takahashi K; Abe R; Usuki S; So M
Transplant Proc; 2014; 46(2):406-10. PubMed ID: 24655975
[TBL] [Abstract][Full Text] [Related]
9. Once-daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendations.
Coilly A; Calmus Y; Chermak F; Dumortier J; Duvoux C; Guillaud O; Houssel-Debry P; Neau-Cransac M; Stocco J
Liver Transpl; 2015 Oct; 21(10):1312-21. PubMed ID: 26264233
[TBL] [Abstract][Full Text] [Related]
10. Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation.
Doesch AO; Mueller S; Akyol C; Erbel C; Frankenstein L; Ruhparwar A; Ehlermann P; Dengler TJ; Katus HA
Drug Des Devel Ther; 2013; 7():1253-8. PubMed ID: 24174870
[TBL] [Abstract][Full Text] [Related]
11. Conversion from twice-daily to once-daily tacrolimus does not reduce intrapatient variability in tacrolimus exposure.
Shuker N; Cadogan M; van Gelder T; Roodnat JI; Kho MM; Weimar W; Hesselink DA
Ther Drug Monit; 2015 Apr; 37(2):262-9. PubMed ID: 25265255
[TBL] [Abstract][Full Text] [Related]
12. Once-daily prolonged-release tacrolimus in de novo liver transplantation: a single center cohort study.
Marubashi S; Wada H; Kobayashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
Hepatogastroenterology; 2012 Jun; 59(116):1184-8. PubMed ID: 22172333
[TBL] [Abstract][Full Text] [Related]
13. Conversion from twice daily tacrolimus to once daily tacrolimus in long-term stable liver transplant recipients: a single-center experience with 394 patients.
Dumortier J; Guillaud O; Boillot O
Liver Transpl; 2013 May; 19(5):529-33. PubMed ID: 23483701
[TBL] [Abstract][Full Text] [Related]
14. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
[TBL] [Abstract][Full Text] [Related]
15. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation.
Beckebaum S; Iacob S; Sweid D; Sotiropoulos GC; Saner F; Kaiser G; Radtke A; Klein CG; Erim Y; de Geest S; Paul A; Gerken G; Cicinnati VR
Transpl Int; 2011 Jul; 24(7):666-75. PubMed ID: 21466596
[TBL] [Abstract][Full Text] [Related]
17. Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism.
Uchida J; Kuwabara N; Machida Y; Iwai T; Naganuma T; Kumada N; Nakatani T
Transplant Proc; 2012 Jan; 44(1):128-33. PubMed ID: 22310596
[TBL] [Abstract][Full Text] [Related]
18. Once-daily prolonged-release tacrolimus versus twice-daily tacrolimus in liver transplantation.
Huang B; Liu J; Li J; Schroder PM; Chen M; Deng R; Deng S
J Am Pharm Assoc (2003); 2019; 59(6):816-823.e2. PubMed ID: 31521585
[TBL] [Abstract][Full Text] [Related]
19. Conversion from twice-daily to once-daily Tacrolimus administration in liver transplant patient: results of long term follow-up.
Giannelli V; Rossi M; Giusto M; Lucidi C; Lattanzi B; Ruffa A; Ginanni Corradini S; Mennini G; Melandro F; Lai Q; Berloco P; Merli M
Eur Rev Med Pharmacol Sci; 2013 Oct; 17(20):2718-20. PubMed ID: 24174352
[TBL] [Abstract][Full Text] [Related]
20. Trough Level and Tacrolimus Variability of Early Converted Once-Daily Tacrolimus: 1-Year Follow-up Study.
Sukkha S; Suansanae T; Iamrahong P; Wiwattanathum P
Transplant Proc; 2020 Apr; 52(3):775-779. PubMed ID: 32143870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
